Sungcad, Ryan C.
HRN: 21-92-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/10/2022
11/17/2022
IV
500mg
Q8hrs
Fistula In Ano
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes